Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aclaris Therapts (NQ: ACRS )

12.11 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 12.11
Bid (Size) 12.08 (26)
Ask (Size) 19.00 (2)
Prev. Close 12.11
Today's Range 12.11 - 12.11
52wk Range 9.260 - 24.00
Shares Outstanding 66,581,903
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Aclaris Therapeutics Q1 Earnings
Aclaris Therapeutics (NASDAQ:ACRS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Airbnb And 3 Other Stocks Insiders Are Selling
Although gold futures traded higher this morning on Tuesday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s... 
Via Benzinga

Performance

YTD
-17.00%
-17.00%
1 Month
-19.80%
-19.80%
3 Month
-9.63%
-9.63%
6 Month
-10.89%
-10.89%
1 Year
-45.77%
-45.77%

More News

Read More
50 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Rises 50 Points; Jefferies Shares Drop
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Mid-Day Market Update: Crude Oil Rises 2%; Philips Shares Plummet
Via Benzinga
28 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
Via Benzinga
Looking Into Aclaris Therapeutics's Return On Capital Employed
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Looking into Aclaris Therapeutics's Return on Capital Employed
Via Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US
Via Benzinga
Exposures COVID-19 Product Safety
75 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Aclaris Therapeutics Shares Plunge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Mid-Day Market Update: Coupa Software Drops After Q1 Results; NextDecade Shares Jump
Via Benzinga
Topics Stocks
Exposures US Equities
50 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Aclaris' ATI-1777 Aces Atopic Dermatitis Trial with Minimal Systemic Exposure
Via Benzinga
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.